Pathway Financial Advisers’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $605K | Buy |
1,492
+107
| +8% | +$43.4K | 0.2% | 116 |
|
|
2025
Q1 | $689K | Buy |
1,385
+55
| +4% | +$27.4K | 0.24% | 106 |
|
|
2024
Q4 | $692K | Sell |
1,330
-93
| -7% | -$48.4K | 0.23% | 110 |
|
|
2024
Q3 | $880K | Sell |
1,423
-27
| -2% | -$16.7K | 0.4% | 73 |
|
|
2024
Q2 | $783K | Buy |
1,450
+33
| +2% | +$17.8K | 0.28% | 103 |
|
|
2024
Q1 | $824K | Sell |
1,417
-284
| -17% | -$165K | 0.3% | 98 |
|
|
2023
Q4 | $903K | Buy |
1,701
+4
| +0.2% | +$2.12K | 0.34% | 86 |
|
|
2023
Q3 | $861K | Buy |
+1,697
| New | +$861K | 0.36% | 82 |
|
|
2023
Q1 | $966K | Sell |
1,675
-1
| -0.1% | -$577 | 0.39% | 78 |
|
|
2022
Q4 | $923K | Buy |
+1,676
| New | +$923K | 0.37% | 78 |
|